QHSLab, Inc. (USAQ)
| Market Cap | 2.79M |
| Revenue (ttm) | 2.29M |
| Net Income (ttm) | -320.32K |
| Shares Out | 11.28M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,850 |
| Average Volume | 15,692 |
| Open | 0.2600 |
| Previous Close | 0.2420 |
| Day's Range | 0.2100 - 0.2600 |
| 52-Week Range | 0.0810 - 0.4729 |
| Beta | 0.77 |
| RSI | 56.07 |
| Earnings Date | May 13, 2025 |
About QHSLab
QHSLab, Inc., a medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics. It develops digital healthcare, clinical decision support and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system QHSLab, cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and... [Read more]
Financial Performance
In 2024, QHSLab's revenue was $2.13 million, an increase of 51.31% compared to the previous year's $1.41 million. Losses were -$259,239, -44.65% less than in 2023.
Financial StatementsNews
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth
WEST PALM BEACH, FL, May 16, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening...
QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025
Revenue increased 32% year-over-year to $645,419, driven by growth in ISP and Allergy Diagnostics Gross margin expanded to 66.6%, reflecting improved product mix and operational efficiencies WEST PALM...
QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program
WEST PALM BEACH, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screenin...
QHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial Results
Four consecutive quarters of year-over-year revenue growth underscore continued business momentum. Revenue surges 98% in Q4 2024 compared to Q4 2023, marking a milestone year for QHSLab.
QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth
Expanding market reach to drive organic revenue growth without equity dilution Collaborating with AI-driven health assessments and customized pharmacy solutions to enhance patient care. Integrating Di...
QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology
NSF Recognition: A Testament to Innovation Driving Strategic Growth and Shareholder Value WEST PALM BEACH, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), a leading pr...
QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024
Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), an emerging leader in digital hea...
QHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy Diagnostics
Revenue Soars 62% Year-Over-Year in Q3 2024, with Gross Margin Expanding to 67.1% Integrated Service Program (ISP) Revenue Up 143% Year-to-Date, Marking Continued Demand for Digital Health Solutions N...
QHSLab, Inc. Welcomes Dr. Juan D. Oms, MD, FAPA, as Medical Advisor for Psychiatry and Behavioral Health
WEST PALM BEACH, FL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proacti...
QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation
WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proact...
QHSLab Inc. Reports Strong Second Quarter and Six-Month 2024 Results
Significant Improvement in Profitability and Cash Flow Management WEST PALM BEACH, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), a leader in digital healthcare and p...
QHSLab, Inc. Announces Strong First Quarter 2024 Results with Significant Reduction in Operating Expenses and Positive Net Operating Income
Integrated Service Program (ISP) Revenues Surge 268% in Q1 2024 Over Q1 2023 WEST PALM BEACH, FL, May 13, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital healt...
QHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs
WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactiv...
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proact...
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare s...
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company
This integration allows QHSLab access to more than 160,000 providers that are the exact match for target providers. WEST PALM BEACH, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) ...
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ● In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from t...
QHSLab Welcomes Six New Integrated Service Program (ISP) Customer Accounts and Launches Enhanced Website for Improved Customer Engagement
WEST PALM BEACH, FL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare so...
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida
WEST PALM BEACH, FL, Feb. 16, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare so...
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are cu...
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
This forecast is based on estimates generated through a recent pilot program and scaled through approximately 250,000 independent primary care practitioners in the United States.
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force
The latest r ecommendations from the U.S. Preventive Services Task Force (U S PSTF) i ndicate that all adults under the age of 65 be screened for anxiety and depression in primary care including child...
QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
Primary care physicians now have access to reimbursable digital tools for the routine assessment of post-COVID conditions
QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
This Partnership Expands QHSLab's Independent Practitioner Network, While Addressing Current Industry Pain Points.
New $90 million annual addressable market for QHSLab's latest product, the Allergy Quick Test, branded AllergiQT™.
WEST PALM BEACH, FL, May 10, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through em...